Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. T. Chu, S. N. Yang, C. H. Hung (Taiwan). Suppressive effects of LABAs over the activation of human MDDCs. Eur Respir J 2010; 36: Suppl. 54, 1737

Member's Comments

No comment yet.

Related content which might interest you: Differing effects of montelukast and ketotifen on cytokine expression in human myeloid dendritic cells Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 Anti-inflammatory efficacy of formoterol via transrepressive mechanisms is independent of the glucocorticoid receptor in human bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 128s Year: 2004 Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 39s Year: 2003 Effects of long-acting β2 agonist on cytokine expression in human plasmacytoid dendritic cells Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010 The effects of inhaled glucocorticoids on human neutrophil apoptosis Source: Eur Respir J 2001; 18: Suppl. 33, 98s Year: 2001 Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 Effects of roflumilast and other PDE4 inhibitors on human CD8+ T-cell functions Source: Eur Respir J 2005; 26: Suppl. 49, 716s Year: 2005 Inhibitory effect of statins on fibrogenic mediator production from lung cells Source: Annual Congress 2012 - Diffuse parenchymal lung disease pathogenesis, biomarkers, therapy and new entities Year: 2012 Effects of JAK-STAT inhibitors on glucocorticosteroid resistant release of CXCR3 chemokines from human bronchial epithelial cells Source: Annual Congress 2011 - Epithelial cell biology Year: 2011 Cigarette smoke-induced IL-8 production by human monocyte-derived macrophages: synergistic inhibition by fluticasone and salmeterol Source: Eur Respir J 2005; 26: Suppl. 49, 14s Year: 2005 Protective effect of thrombomodulin-positive dendritic cells against murine asthma Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010 Modulatory effects of immunosuppressives on IL-8 and GM-CSF expression in bronchial and alveolar epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 854s Year: 2006 Modulation of pro-inflammatory and anti-viral responses in BEAS2B cells by glucocorticoid agonists Source: International Congress 2017 – Towards new anti-inflammatory and anti-fibrotic agents Year: 2017 Synergistic effect of fluticasone propionate and salmeterol on T-lymphocytes in inhibiting proliferation in vitro Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009 Differential effects of simvastatin and dexamethasone on TLR3-induced anti-viral cytokines in asthmatic epithelium Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Synergistic suppression of human rhinovirus induced pro-inflammatory cytokines by B2 agonists and glucocorticoids Source: Annual Congress 2004 - Mechanisms and treatment of virus induced asthma exacerbations Year: 2004 HDAC2-independent anti-inflammatory effects of budesonide in human lung fibroblasts Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Effects of long-acting beta2 agonists on Th1 and Th2 chemokines in monocytes and bronchial epithelial cells Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Tiotropium enhances the inhibitory effect of the long acting β2-agonist olodaterol on the release of IL-6 and IL8 by primary human lung fibroblasts of asthma patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012